Breadcrumb
- Home
- IDDI Workstreams & Task Forces
- Women's Health Task Force
Women's Health Task Force
Big news: the Women’s Health Task Force is back!
We’re thrilled to announce the re-launch of the Women’s Health Task Force - now co-chaired by Dr. Jessica Badlam, University of Vermont Medical Center, and Dr. Daria Kostyunina, Imperial College London.
The Women’s Health Task Force is a revitalised PVRI initiative committed to advancing care, outcomes, and research for women affected by PVD.
Relaunch webinar
To kick things off, we hosted a dedicated webinar in September 2025, featuring expert presentations that explored the intersection of women’s health and PVD.
The webinar included:
- Background and PHANTOM trial results - Steve Kawut, University of Pennsylvania School of Medicine
- Pregnancy and PAH and/or PHAR data on sex disparities - Jackie DesJardin, UCSF Health
- Proposed aims and objectives for the Task Force, incorporating participant input and discussion - Jessica Badlam, University of Vermont Medical Center & Meghan Cirulis, Intermountain Health Intermountain Medical Center
Missed it? Watch the recording here
The Task Force aims to:
- Foster global collaboration to improve knowledge, encourage research, and optimise delivery of clinical care to women with pulmonary vascular disease
- Engage and support efforts in the investigation into sex differences, including the female predominance, in pulmonary arterial hypertension
- Advance knowledge and provide guidance on pregnancy and reproductive health in women with pulmonary hypertension
- Support and encourage women investigators in pulmonary vascular disease wherever they live in the world
If you are interested in joining this Task Force, please get in touch - we’d love to hear from you.
Let’s move women’s health forward — together.
Leaders
IDDI Workstreams and Task Forces
Want to be part of something special?
All PVRI members are welcome to join an IDDI Workstream or a Task Force.
2025–26 IDDI Workstream & Task Forces Report
PVRI’s latest report highlights how global IDDI Workstreams and Task Forces are accelerating progress in pulmonary hypertension research, care, and innovation. Discover key achievements from across regions and specialties.
Interested in accessing global data on PH patient experience?
Almost 4,000 patients and carers across 85 countries completed Phase 1 of our PH Global Patient Survey (PHGPS). Questions across all PH groups included diagnostic tests & timelines, genetic testing, treatments, financial burdens, hospital visits, research participation, quality of life, telemedicine, patient-reported outcome measures, and self-monitoring with digital technology. The findings have the potential to improve patient care, guide future research and help us address unmet needs.
Our Regional Task Forces don't yet have global coverage. If you're interested in starting one, please contact us.